InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

Current share price for OCC : $0.670 0.025 (3.88%)+

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$183 Notification regarding unquoted securities - OCC 24 Oct 2025 9:50AM $1.265 $0.670 fallen by 47.04%
$183 Cleansing Notice 24 Oct 2025 9:50AM $1.265 $0.670 fallen by 47.04%
$183 Application for quotation of securities - OCC 24 Oct 2025 9:46AM $1.265 $0.670 fallen by 47.04%
$183 Cleansing Notice 21 Oct 2025 4:32PM $1.305 $0.670 fallen by 48.66%
$183 Application for quotation of securities - OCC 21 Oct 2025 4:30PM $1.305 $0.670 fallen by 48.66%
$183 OCC Secures Rights to High-Value Bone Regeneration Tech 20 Oct 2025 8:56AM $1.310 $0.670 fallen by 48.85%
$183 Letter, Supplementary Notice of AGM & Replacement Proxy Form 17 Oct 2025 4:29PM $1.310 $0.670 fallen by 48.85%
$183 Proposed issue of securities - OCC 17 Oct 2025 9:19AM $1.430 $0.670 fallen by 53.15%
$183 $30m Placement Sees Orthocell Positioned for Rapid Growth 17 Oct 2025 9:18AM $1.430 $0.670 fallen by 53.15%
$183 Trading Halt 15 Oct 2025 9:19AM $1.430 $0.670 fallen by 53.15%
$183 Quarterly Activity Report & Appendix 4C 10 Oct 2025 9:01AM $1.440 $0.670 fallen by 53.47%
$183 Annual Report to Shareholders 3 Oct 2025 4:06PM $1.470 $0.670 fallen by 54.42%
$183 Letter to Shareholders, Notice of AGM & Proxy Form 3 Oct 2025 4:04PM $1.470 $0.670 fallen by 54.42%
$183 Another Record Revenue Quarter for Orthocell 2 Oct 2025 8:55AM $1.435 $0.670 fallen by 53.31%
$183 Cleansing Notice 30 Sep 2025 5:58PM $1.415 $0.670 fallen by 52.65%
$183 Application for quotation of securities - OCC 30 Sep 2025 5:55PM $1.415 $0.670 fallen by 52.65%
$183 First Distributor signed for Remplir in $75m Canadian Market 30 Sep 2025 8:57AM $1.245 $0.670 fallen by 46.18%
$183 Remplir Use in Prostate Surgery Signals Global Opportunity 16 Sep 2025 9:05AM $1.100 $0.670 fallen by 39.09%
$183 Date of AGM & Closing Date for Director Nominations 10 Sep 2025 7:11PM $1.150 $0.670 fallen by 41.74%
$183 Compelling 81% Success Rate for Remplir 8 Sep 2025 9:03AM $1.130 $0.670 fallen by 40.71%
$183 Cleansing Notice 3 Sep 2025 4:35PM $1.130 $0.670 fallen by 40.71%
$183 Application for quotation of securities - OCC 3 Sep 2025 4:32PM $1.130 $0.670 fallen by 40.71%
$183 Replacement Initial Director's Interest Notice 1 Sep 2025 4:56PM $1.160 $0.670 fallen by 42.24%
$183 Notification regarding unquoted securities - OCC 1 Sep 2025 4:48PM $1.160 $0.670 fallen by 42.24%
$183 Initial Director's Interest Notice - Mr Michael McNulty 1 Sep 2025 4:38PM $1.160 $0.670 fallen by 42.24%

76 - 100 of 772 results

Page 4 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.